World's Best Scientists 2026 revealed!
Award Badge
Medicine
Sweden
2023

D-Index & Metrics

Medicine

D-Index
121
Citations
119177
World Ranking
3515
National Ranking
70

Hans Wedel publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Hans Wedel sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 343 publications — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Hans Wedel D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Hans Wedel sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 121 D-Index — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in Sweden Leader Award

Overview

Hans Wedel is affiliated with the Nordic School of Public Health in Sweden. The primary focus of their research lies in Medicine, particularly within the subfields of Endocrinology, Diabetes and Metabolism, Genetics, Nephrology, Obstetrics and Gynecology, and Dermatology.

The main research topics Hans Wedel has contributed to include:

  • Diabetes Management and Research
  • Diabetes Treatment and Management
  • Diabetic Foot Ulcer Assessment and Management
  • Diabetes and Associated Disorders
  • Chronic Kidney Disease and Diabetes
  • Gestational Diabetes Research and Management
  • Skin Diseases and Diabetes

Hans Wedel has published extensively across multiple reputable venues, with frequent publications in:

  • Diabetes
  • Diabetologia
  • The Lancet Regional Health - Europe
  • Acta Diabetologica

Selected recent papers authored or co-authored by Hans Wedel include:

  • "Risk factors and incidence over time for lower extremity amputations in people with type 1 diabetes: an observational cohort study of 46,088 patients from the Swedish National Diabetes Registry," 2021, Diabetologia
  • "Risk factors, mortality trends, and cardiovascular diseases in people with Type 1 diabetes and controls in Sweden: An observational cohort study," 2022, The Lancet Regional Health - Europe
  • "Risk factors for nephropathy in persons with type 1 diabetes: a population-based study," 2022, Acta Diabetologica
  • "527-P: Risk Factors for Nephropathy among Children and Young Adults with Type 1 Diabetes: A Swedish Cohort," 2020, Diabetes
  • "52-OR: Risk Factors and Incidence over Time for Lower Extremity Amputations in Persons with Type 1 Diabetes: An Observational Cohort Study of 46,008 Patients from the Swedish National Diabetes Registry," 2021, Diabetes

Hans Wedel's frequent collaborators include:

  • Marcus Lind
  • Ann-Marie Svensson
  • Aldina Pivodic
  • Sara Hallström
  • Johnny Ludvigsson

Best Publications

  • Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial

    Lennart Hansson;Alberto Zanchetti;S George Carruthers;Björn Dahlöf

  • Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

    Björn Dahlöf;Richard B Devereux;Sverre E Kjeldsen;Stevo Julius

  • Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

    S. Sans;A. Menotti;G. De Backer;D. De Bacquer

  • Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery

    L. Sjöström;A.-K. Lindroos;M. Peltonen

  • Effects of bariatric surgery on mortality in Swedish obese subjects.

    Lars Sjöström;Kristina Narbro;C. David Sjöström;Kristjan Karason

  • Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

    Deborah Marshall;Olof Johnell;Hans Wedel

  • Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

    Peter S Sever;Björn Dahlöf;Neil R Poulter;Hans Wedel

  • Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

    A. Hjalmarson;S. Goldstein;B. Fagerberg;H. Wedel

  • Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial

    Björn Dahlöf;Peter S Sever;Neil R Poulter;Hans Wedel

  • Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year

    Klas Malmberg;Lars Rydén;Suad Efendic;Johan Herlitz

  • Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

    Lars H Lindholm;Hans Ibsen;Björn Dahlöf;Richard B Devereux

  • Rosuvastatin in Older Patients with Systolic Heart Failure

    John Kjekshus;Eduard Apetrei;Vivencio Barrios;Michael Böhm

  • Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients With Heart Failure: The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)

    A. Hjalmarson;S. Goldstein;B. Fagerberg;H. Wedel

  • Bariatric Surgery and Long-term Cardiovascular Events

    Lars Sjöström;Markku Peltonen;Peter Jacobson;C. David Sjöström

  • Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity

    K Malmberg;Lars Rydén;H Wedel;K Birkeland

  • Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial.

    Å Hjalmarson;Johan Herlitz;I Málek;L Rydén

  • Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

    Karl Swedberg;Peter Held;John Kjekshus;Knut Rasmussen

  • Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Infarction Long-Term Results From the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) Study

    Klas Malmberg;Anna Norhammar;Hans Wedel;Lars Rydén

  • Association of Bariatric Surgery With Long-term Remission of Type 2 Diabetes and With Microvascular and Macrovascular Complications

    Lars Sjöström;Markku Peltonen;Peter Jacobson;Sofie Ahlin

  • Intense Metabolic Control by Means of Insulin in Patients With Diabetes Mellitus and Acute Myocardial Infarction (DIGAMI 2): Effects on Mortality and Morbidity

    K. Malmberg;L. Rydén;H. Wedel

Frequent Co-Authors

Lars Wilhelmsen
Lars Wilhelmsen University of Gothenburg
Björn Dahlöf
Björn Dahlöf Sahlgrenska University Hospital
Sverre E. Kjeldsen
Sverre E. Kjeldsen University of Oslo
Markku S. Nieminen
Markku S. Nieminen University of Helsinki
John Kjekshus
John Kjekshus University of Oslo
Peter S. Sever
Peter S. Sever Imperial College London
Neil R. Poulter
Neil R. Poulter Imperial College London
Richard B. Devereux
Richard B. Devereux Cornell University
Suzanne Oparil
Suzanne Oparil University of Alabama at Birmingham
Ulf de Faire
Ulf de Faire Karolinska Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring additional healthcare degrees online can open up a variety of career options. For those interested in mental health, psych np programs offer specialized training to become a Psychiatric Nurse Practitioner. These programs are ideal for nurses who want to focus on mental wellness and psychiatric care.

Healthcare administration is another fast-growing field. If you’re looking for a management or leadership role, consider pursuing one of the cheapest mha programs online. These affordable degrees prepare students for high-level positions in hospitals, clinics, or healthcare organizations.

For further cost-effective options, explore other cheap mha programs that balance quality with affordability, making career advancement more accessible.

For those aiming for the highest clinical and leadership roles in nursing, the cheapest dnp programs offer a flexible path to a Doctor of Nursing Practice. These programs are designed for working nurses seeking to advance their expertise without putting their careers on hold.

Best Scientists Citing Hans Wedel

Trending Scientists

Recently Published Articles